Evidence map›Paper›PMID 37798288›Full record

ArticleNature communications2023

Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates.

Payton A-B Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, Prabhu S Arunachalam, Mengyun Hu, Ozan S Kumru, Mary Kate Morris, Jane Fontenot, Lisa Shirreff and 10 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Payton A-B Weidenbacher *Sarafan ChEM-H, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-7692-0458
Mrinmoy Sanyal *Sarafan ChEM-H, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-1365-4279
Natalia Friedland *Sarafan ChEM-H, Stanford University, Stanford, CA, USA.
Shaogeng TangSarafan ChEM-H, Stanford University, Stanford, CA, USA.
Prabhu S ArunachalamInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-0090-5689
Mengyun HuInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-4495-7501
Ozan S KumruVaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA.ORCID http://orcid.org/0000-0002-5010-7223
Mary Kate MorrisCalifornia Department of Public Health, Richmond, CA, USA.
Jane FontenotNew Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA.
Lisa ShirreffNew Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA.ORCID http://orcid.org/0000-0002-8403-451X
Jonathan DoSarafan ChEM-H, Stanford University, Stanford, CA, USA.
Ya-Chen ChengSarafan ChEM-H, Stanford University, Stanford, CA, USA.
Gayathri VasudevanIAVI, New York, NY, USA.
Mark B FeinbergIAVI, New York, NY, USA.
Francois J VillingerNew Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA.
Carl HansonCalifornia Department of Public Health, Richmond, CA, USA.
Sangeeta B JoshiVaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA.
David B VolkinVaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA.
Bali PulendranInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-6517-4333
Peter S KimSarafan ChEM-H, Stanford University, Stanford, CA, USA. kimpeter@stanford.edu.ORCID http://orcid.org/0000-0001-6503-4541
Stanford University · USUniversity of Kansas · USUniversity of Louisiana at Lafayette · USCalifornia Department of Public Health · USInternational AIDS Vaccine Initiative · USChan Zuckerberg Initiative (United States) · US

Funding

Systems biological assessment of T cell responses to vaccinationU19AI167903 · NIAID · STANFORD UNIVERSITY · PI BALI PULENDRAN · 2022 to 2026
$13.2M
NIAID NIH HHS U19 AI167903
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37798288
PMCPMC10556009
OpenAlexW4387374502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.